Breakthrough drug works against all the main types of primary bone cancer
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
India’s largest renewable power generation company has announced that it successfully commissioned a 700 megawatt solar-wind hybrid project in the northern state of Rajasthan.
Among the new professions available to female domestic workers are driver, personal care worker, home tailor, home manager, private tutor and home farmer.
In 2006, the U.S. EPA banned the agricultural use of lindane, linked to anemia, lung cancer, and lymphoma. In 2010, it began to phase out endosulfan, which experts say may damage the liver and kidneys.
The expungement is the latest byproduct of the constitutional amendment approved by Missouri voters, which legalized pot for adults and cleared the way for Missourians to have their records cleared.
More than 190 countries have approved the UN High Seas Treaty, establishing a framework for creating new protected areas and includes provisions on transferring technology, sharing scientific findings, and coordinating the study of environmental threats.
NHS data suggests the gas, used to keep people unconscious during surgery, has a global warming potential 2,500 times greater than carbon dioxide.
For ages, caste has governed nearly every aspect of Hindu religious and social life, with each group maintaining a distinct position in this complicated hierarchy.
The law adds sexual orientation and gender identity to the state’s law prohibiting discrimination based on individual characteristics in housing, employment, and public accommodation in public services and educational facilities.
Insulin costs in the U.S. are notoriously high compared to the costs in other countries; the Rand Corporation, a public policy think tank, estimated that in 2018, the average list price for one vial of insulin in the U.S. was $98.70.